SCM
LLY icon

Sirios Capital Management’s Eli Lilly LLY Stock Holding History

Sirios Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.17M Sell
7,643
-443
-5% -$453K 1.11% 27
2026
Q1 		$7.44M Sell
8,086
-2,169
-21% -$2.2M 0.9% 36
2025
Q4 		$11M Sell
10,255
-3,671
-26% -$3.51M 1.37% 27
2025
Q3 		$10.6M Buy
13,926
+1,629
+13% +$1.21M 1.38% 27
2025
Q2 		$9.59M Sell
12,297
-2,378
-16% -$1.85M 1.39% 25
2025
Q1 		$12.1M Sell
14,675
-700
-5% -$582K 2.16% 15
2024
Q4 		$11.9M Sell
15,375
-465
-3% -$385K 2.13% 16
2024
Q3 		$14M Sell
15,840
-3,374
-18% -$3.03M 2.48% 14
2024
Q2 		$17.4M Sell
19,214
-260
-1% -$208K 3.03% 12
2024
Q1 		$15.1M Sell
19,474
-9,599
-33% -$6.83M 2.85% 13
2023
Q4 		$16.9M Sell
29,073
-4,816
-14% -$2.81M 3.46% 10
2023
Q3 		$18.2M Sell
33,889
-2,475
-7% -$1.28M 3.45% 7
2023
Q2 		$17.1M Sell
36,364
-2,247
-6% -$942K 2.95% 12
2023
Q1 		$13.3M Sell
38,611
-1,424
-4% -$480K 2.34% 16
2022
Q4 		$14.6M Sell
40,035
-9,829
-20% -$3.48M 2.7% 14
2022
Q3 		$16.1M Sell
49,864
-4,438
-8% -$1.41M 2.99% 13
2022
Q2 		$17.6M Sell
54,302
-1,508
-3% -$453K 3.18% 11
2022
Q1 		$16M Sell
55,810
-30,451
-35% -$7.84M 2.13% 17
2021
Q4 		$23.8M Sell
86,261
-7,098
-8% -$1.8M 2.73% 12
2021
Q3 		$21.6M Sell
93,359
-14,723
-14% -$3.63M 2.26% 14
2021
Q2 		$24.8M Sell
108,082
-74,693
-41% -$15M 2.16% 14
2021
Q1 		$34.1M Sell
182,775
-59,345
-25% -$11.6M 2.88% 9
2020
Q4 		$40.9M Sell
242,120
-60,931
-20% -$9.1M 3.18% 7
2020
Q3 		$44.9M Buy
+303,051
New +$46.9M 3.66% 5

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sirios Capital Management's LLY Position: Q2 2026 in Review

Sirios Capital Management reduced its Eli Lilly (LLY) stake by 5.5% in Q2 2026, selling an estimated $453K and leaving 7,643 shares worth $9.17M. The position accounts for 1.11% of the portfolio, ranked #27.

Sirios Capital Management first reported a position in LLY in Q3 2020 and has held it in 24 quarters since. The position peaked at $44.9M in Q3 2020. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sirios Capital Management held 7,643 shares of Eli Lilly worth $9.17M as of Q2 2026.
  • Sirios Capital Management sold 443 Eli Lilly shares in Q2 2026, an estimated $453K.
  • Eli Lilly made up 1.11% of Sirios Capital Management's portfolio in Q2 2026, its #27 holding.
  • Sirios Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 24 quarters since.
  • Sirios Capital Management's Eli Lilly position peaked at $44.9M in Q3 2020.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sirios Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.